233 Followers on Owler
Meditope Biosciences develops novel antibody-based cancer products using its SnAP technology...
Read moreMeditope Biosciences develops novel antibody-based cancer products using its SnAP technology...
Read more
2011
PrivateIndependent Company
News
Jul 10, 2018
Benzinga
Meditope Biosciences: Meditope Biosciences Appoints Veteran Biopharma Scientist David Stover to Board of Directors
Apr 24, 2018
EconoTimes
Press Release: Meditope Biosciences : Meditope Receives BioLabs Golden Ticket Award From Sanofi to Advance Bioconjugation Technology Research
Aug 30, 2016
BioSpace
Meditope Biosciences: Meditope Biosciences Expands Patent Portfolio With Issuance Of Additional U.S. Patent
Apr 18, 2016
BioSpace
Meditope Biosciences: Meditope Biosciences Announces Data At AACR Annual Meeting Demonstrating Further Capabilities Of Its SnAP Technology
Sep 23, 2015
SEC
Meditope Biosciences: Received $1.6M in Equity Funding
Apr 20, 2015
SYS-CON MEDIA
Meditope Biosciences: Meditope Biosciences Presents Data At The American Association Of Cancer Research (AACR) Annual Meeting Validating Its SnAP Technology Platform
Apr 20, 2015
PR NEWSWIRE
Press Release: Meditope Biosciences : Meditope Biosciences Presents Data At The American Association Of Cancer Research (AACR) Annual Meeting Validating Its SnAP Technology Platform
Feb 25, 2015
BIOSPACE
Meditope Biosciences: Meditope Biosciences Announces Issuance Of Additional Patent For SnAP Technology
Jan 07, 2015
PR NEWSWIRE
Press Release: Meditope Biosciences : Meditope Biosciences Enhances Leadership Team With New Executive And Board Appointments
May 19, 2014
BIOSPACE
Meditope Biosciences: Meditope Biosciences Appoints As Vice President Of Translational Research
Looking for similar companies to Meditope?
Meditope News
Meditope Press Releases
Meditope Headquarters
Meditope Summary
ABOUT
Overview
Meditope Biosciences develops novel antibody-based cancer products using its SnAP technology. Meditope was founded in 2011. Meditope's headquarters is located in Pasadena, California, USA 91105. Meditope's President & CEO, Stephanie Hsieh, currently ...CEO
Meditope's President & CEO, Stephanie Hsieh, currently has an approval rating of 82%. Meditope's primary competitors are ADC Therapeutics, CytomX, ADC Bio and 12 more.Website
meditope.comCompetitors
View 15 Meditope competitors here.Acquisitions
There have been no acquisitions found related to MeditopeInvestments
Recent investment data cannot be found related to MeditopeFrequently Asked Questions about Meditope
When was Meditope founded?
Meditope was founded in 2011Who is Meditope's CEO?
Meditope's CEO is Stephanie HsiehHow much revenue does Meditope generate?
Meditope generates $9.8M in revenueHow much funding does Meditope have?
Meditope has historically raised $7.3M in funding
Where is Meditope's headquarters?
Meditope's headquarters is in Pasadena California, USAHow many employees does Meditope have?
Meditope has 30 employeesWhat sector does Meditope operate in?
Meditope is in BiotechnologyWho are Meditope's competitors?
Meditope's top competitors are ADC Therapeutics, CytomX, ADC Bio